29.01.2014 • NewsDede WillamsACCAmerican Chemistry Council

American Chemicals Recovery “Slow and Steady”

The first Chemical Activity Barometer (CAB) of 2014, published by the American Chemistry Council (ACC) on Jan. 28, sees the U.S. economy continuing to grow. In January, the barometer notched up to 94.0, a rise of 0.2 points against December, and is 2.6% ahead of the same point of 2013, the ACC said.

"Slow and steady isn't a bad thing when you consider the alternative," said Kevin Swift, chief economist at the chemistry council. He added that the economic recovery seems to be lagging compared to previous post-recession recoveries, but overall the fundamentals remain strong.

The ongoing expansion in chemistries related to construction and consumer-related resins, as well as light vehicle sales, Swift said. A "particularly bright spot," he added, are recent strong gains in electronic chemicals, food additives, foundry chemicals, lubricant and paint additives, mining chemicals and printing ink.

Overall, ACC said, the four primary components of the CAB were mixed, with production and inventories up, selling prices flat and equity prices declining.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.